Zhang Ming, Sun Kaiji, Wu Yujun, Yang Ying, Tso Patrick, Wu Zhenlong
State Key Laboratory of Animal Nutrition, Department of Animal Nutrition and Feed Science, China Agricultural University, Beijing, China.
Department of Pathology and Laboratory Medicine, Metabolic Diseases Institute, University of Cincinnati, Cincinnati, OH, United States.
Front Immunol. 2017 Aug 14;8:942. doi: 10.3389/fimmu.2017.00942. eCollection 2017.
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract. Although the etiology and pathogenesis of IBD remain unclear, both genetic susceptibility and environmental factors are implicated in the initiation and progression of IBD. Recent studies with experimental animal models and clinical patients indicated that the intestinal microbiota is one of the critical environmental factors that influence nutrient metabolism, immune responses, and the health of the host in various intestinal diseases, including ulcerative colitis and Crohn's disease. The objective of this review is to highlight the crosstalk between gut microbiota and host immune response and the contribution of this interaction to the pathogenesis of IBD. In addition, potential therapeutic strategies targeting the intestinal micro-ecosystem in IBD are discussed.
炎症性肠病(IBD)是一种胃肠道的慢性炎症性疾病。尽管IBD的病因和发病机制仍不清楚,但遗传易感性和环境因素都与IBD的发生和发展有关。最近对实验动物模型和临床患者的研究表明,肠道微生物群是影响各种肠道疾病(包括溃疡性结肠炎和克罗恩病)中营养代谢、免疫反应和宿主健康的关键环境因素之一。本综述的目的是强调肠道微生物群与宿主免疫反应之间的相互作用,以及这种相互作用对IBD发病机制的影响。此外,还讨论了针对IBD肠道微生态系统的潜在治疗策略。